RXST logo

RXST

RxSight Inc.

$10.15
+$1.20(+13.41%)
42
Overall
60
Value
25
Tech
--
Quality
Market Cap
$394.72M
Volume
1.13M
52W Range
$6.32 - $47.89
Target Price
$9.67

Company Overview

Mkt Cap$394.72MPrice$10.15
Volume1.13MChange+13.41%
P/E Ratio-14.4Open$9.03
Revenue$139.9MPrev Close$8.95
Net Income$-27.5M52W Range$6.32 - $47.89
Div YieldN/ATarget$9.67
Overall42Value60
Quality--Technical25

No chart data available

About RxSight Inc.

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing

Latest News

Analysts Offer Insights on Healthcare Companies: Cencora (COR), RxSight (RXST) and Acadia Healthcare (ACHC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cencora (COR – Research Report), RxSight (RXST – Research Report)...

Howard Kim17 days ago
ABCD
1SymbolPriceChangeVol
2RXST$10.15+13.4%1.13M
3
4
5
6

Get RxSight Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.